Before Invest
ABBOTT LABORATORIES logo

ABBOTT LABORATORIES

ABT
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 30, 2026
Financial Statements Ratios
Export XLSX
Statement
Income StatementBalance Sheet
Period
Annual Quarterly
Order
Unlock 40 quarters
Format
% Change
Rows
USD ($)
$ in Millions 		Jun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016Sep 30, 2015Jun 30, 2015Mar 31, 2015Sep 30, 2014Jun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012Jun 30, 2012Mar 31, 2012Sep 30, 2011Jun 30, 2011Mar 31, 2011Sep 30, 2010Jun 30, 2010Mar 31, 2010Sep 30, 2009Jun 30, 2009
Current Assets:
                                                    
Cash and cash equivalents
$ 5,104
$ 6,803
$ 7,511
$ 6,951
$ 6,532
$ 7,558
$ 6,987
$ 6,284
$ 6,709
$ 7,835
$ 9,161
$ 9,594
Short-term investments
499
492
222
331
312
230
232
367
338
320
371
313
Restricted funds, primarily U.S. treasury bills
-
-
-
-
-
-
-
-
-
-
-
-
Trade receivables, less allowances of $486 in 2026 and $490 in 2025
8,599
8,210
8,138
7,972
7,327
7,051
6,854
6,605
6,499
6,172
6,020
6,408
Inventories:
                                                    
Finished products
4,512
4,274
4,130
4,319
4,063
4,173
4,060
4,063
3,847
4,004
3,944
3,407
Work in process
1,023
994
961
962
890
877
880
881
888
845
805
726
Materials
1,780
1,721
1,617
1,673
1,686
1,763
1,874
1,883
1,915
2,022
1,924
1,601
Total inventories
7,315
6,989
6,708
6,954
6,639
6,813
6,814
6,827
6,650
6,871
6,673
5,734
Prepaid expenses and other receivables
3,000
3,014
2,260
2,260
2,343
2,150
2,232
2,293
2,468
2,307
2,152
2,796
Current assets held for disposition
-
-
-
-
-
-
-
-
-
-
-
-
Total Current Assets
24,517
25,508
24,839
24,468
23,153
23,802
23,119
22,376
22,664
23,505
24,377
24,845
Investments
1,111
1,090
951
958
907
912
877
818
788
799
776
764
Property and equipment, at Cost:
                                                    
Property and equipment, at cost
26,469
25,737
24,816
24,472
23,418
22,857
22,061
22,055
21,111
20,926
20,605
19,306
Less: accumulated depreciation and amortization
13,657
13,360
13,312
13,077
12,486
12,236
11,828
11,948
11,559
11,477
11,323
10,617
Net property and equipment
12,812
12,377
11,504
11,395
10,932
10,621
10,233
10,107
9,552
9,449
9,282
8,689
Intangible assets, net of amortization
17,211
17,875
5,598
5,920
6,261
7,352
7,827
8,296
9,282
9,834
10,006
10,850
Goodwill
35,244
35,221
23,971
23,952
23,359
23,658
23,308
23,383
23,277
23,258
22,927
22,284
Deferred income taxes and other assets
18,320
18,358
17,318
17,306
16,836
8,011
7,653
7,487
6,527
6,509
6,426
5,369
Non-current assets held for disposition
-
-
-
-
-
-
-
-
-
-
-
-
Total Assets
109,215
110,429
84,181
83,999
81,448
74,356
73,017
72,467
72,090
73,354
73,794
72,801
Liabilities and Shareholders’ Investment
                                                    
Current Liabilities:
                                                    
Short-term borrowings
-
-
-
-
-
-
-
-
-
-
-
-
Trade accounts payable
4,794
4,679
4,123
4,306
4,214
4,034
4,125
4,178
3,961
4,211
4,167
4,133
Salaries, wages, and commissions
1,619
1,212
1,735
1,550
1,167
1,618
1,389
1,092
1,479
1,362
1,098
1,426
Other accrued liabilities
6,892
6,379
5,880
5,656
5,600
5,427
5,071
5,220
5,347
5,334
5,758
5,475
Dividends payable
1,093
1,100
1,030
1,030
1,032
956
959
959
886
886
888
820
Income taxes payable
411
598
469
390
485
713
601
562
318
273
334
394
Current portion of long-term debt
3,005
4,409
1,345
507
506
2,154
1,615
2,010
1,051
2,284
2,285
1,117
Current liabilities held for disposition
-
-
-
-
-
-
-
-
-
-
-
-
Total Current Liabilities
17,814
18,377
14,582
13,439
13,004
14,902
13,760
14,021
13,042
14,350
14,530
13,365
Long-term debt
29,603
29,638
11,596
12,930
12,736
12,825
13,139
12,576
14,477
14,562
14,615
15,297
Post-employment obligations, deferred income taxes, and other long-term liabilities
10,036
9,713
6,739
6,801
6,644
6,601
6,558
6,827
6,877
7,038
7,417
8,255
Non-current liabilities held for disposition
-
-
-
-
-
-
-
-
-
-
-
-
Shareholders’ Investment:
                                                    
Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued
0
0
0
0
0
0
0
0
0
0
0
0
Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2026: 1,998,291,279; 2025: 1,996,795,525
25,495
25,352
25,412
25,284
25,125
25,020
24,858
24,726
24,727
24,612
24,488
24,560
Common shares held in treasury, at cost — Shares: 2026: 267,907,258; 2025: 260,196,074
17,967
16,935
16,877
16,610
16,612
16,476
15,759
15,761
15,686
15,722
15,307
14,555
Earnings employed in the business
49,794
49,956
49,103
48,467
47,715
39,056
38,354
38,011
36,920
36,355
35,868
35,115
Accumulated other comprehensive income (loss)
(6,212)
(6,312)
(6,684)
(6,576)
(7,417)
(7,804)
(8,135)
(8,166)
(8,480)
(8,071)
(8,039)
(9,445)
Total Abbott Shareholders’ Investment
51,110
52,061
50,954
50,565
48,811
39,796
39,318
38,810
37,481
37,174
37,010
35,675
Noncontrolling interests
652
640
310
264
253
232
242
233
213
230
222
209
Total Shareholders’ Investment
51,762
52,701
51,264
50,829
49,064
40,028
39,560
39,043
37,694
37,404
37,232
35,884
Total Liabilities and Shareholders' Investment
$ 109,215
$ 110,429
$ 84,181
$ 83,999
$ 81,448
$ 74,356
$ 73,017
$ 72,467
$ 72,090
$ 73,354
$ 73,794
$ 72,801